These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37804609)

  • 1. Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.
    Honea RA; Hunt S; Lepping RJ; Vidoni ED; Morris JK; Watts A; Michaelis E; Burns JM; Swerdlow RH
    Neurobiol Aging; 2023 Dec; 132():131-144. PubMed ID: 37804609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study.
    Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA
    J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles.
    Roses AD; Lutz MW; Saunders AM; Goldgaber D; Saul R; Sundseth SS; Akkari PA; Roses SM; Gottschalk WK; Whitfield KE; Vostrov AA; Hauser MA; Allingham RR; Burns DK; Chiba-Falek O; Welsh-Bohmer KA
    Alzheimers Dement; 2014 Nov; 10(6):592-601.e2. PubMed ID: 25260913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of
    Nishimura A; Nonomura H; Tanaka S; Yoshida M; Maruyama Y; Aritomi Y; Saunders AM; Burns DK; Lutz MW; Runyan G; Lai E; Budur K; Roses AD
    Alzheimers Dement (N Y); 2017 Nov; 3(4):524-530. PubMed ID: 29124110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
    Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
    Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    Siddarth P; Burggren AC; Merrill DA; Ercoli LM; Mahmood Z; Barrio JR; Small GW
    PLoS One; 2018; 13(12):e0208358. PubMed ID: 30517207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    Cardoso R; Lemos C; Oliveiros B; Almeida MR; Baldeiras I; Pereira CF; Santos A; Duro D; Vieira D; Santana I; Oliveira CR
    J Alzheimers Dis; 2020; 78(2):587-601. PubMed ID: 33016906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    Neurology; 2017 Feb; 88(7):661-668. PubMed ID: 28108637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
    Johnson SC; La Rue A; Hermann BP; Xu G; Koscik RL; Jonaitis EM; Bendlin BB; Hogan KJ; Roses AD; Saunders AM; Lutz MW; Asthana S; Green RC; Sager MA
    Alzheimers Dement; 2011 Jul; 7(4):456-65. PubMed ID: 21784354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.
    Burggren AC; Mahmood Z; Harrison TM; Siddarth P; Miller KJ; Small GW; Merrill DA; Bookheimer SY
    Alzheimers Dement; 2017 Jul; 13(7):739-748. PubMed ID: 28183529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases.
    Soyal SM; Kwik M; Kalev O; Lenz S; Zara G; Strasser P; Patsch W; Weis S
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1317. PubMed ID: 32472747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease biomarkers.
    Kulminski AM; Jain-Washburn E; Loiko E; Loika Y; Feng F; Culminskaya I;
    Aging (Albany NY); 2022 Nov; 14(24):9782-9804. PubMed ID: 36399096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.
    Shao Y; Shaw M; Todd K; Khrestian M; D'Aleo G; Barnard PJ; Zahratka J; Pillai J; Yu CE; Keene CD; Leverenz JB; Bekris LM
    J Hum Genet; 2018 Apr; 63(4):459-471. PubMed ID: 29371683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals.
    Cacciaglia R; Molinuevo JL; Falcón C; Sánchez-Benavides G; Gramunt N; Brugulat-Serrat A; Esteller M; Morán S; Fauria K; Gispert JD;
    Neuroimage Clin; 2019; 23():101818. PubMed ID: 30991302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.